Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11239-021-02436-0.pdf
Reference21 articles.
1. Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. https://coronavirus.jhu.edu/map.html. Accessed 26 Dec, 2020
2. Signorelli SS, Platania I, Tomasello SD et al (2020) Insights from experiences on antiplatelet drugs in stroke prevention: a review. Int J Environ Res Public Health 17(16):5840
3. Connelly (2014) A history of aspirin. Pharm J 6(7):20066661
4. Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M (2020) Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19 ? Drugs 80(14):1383–1396
5. Gu SX, Tyagi T, Jain K et al (2020) Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 18(3):194–209
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impacto del uso previo de antiagregantes plaquetarios en la susceptibilidad, la progresión y la gravedad de la COVID-19: un estudio poblacional;Revista Española de Cardiología;2024-07
2. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study;Revista Española de Cardiología (English Edition);2024-07
3. Diverse roles of SARS-CoV-2 Spike and Nucleocapsid proteins in EndMT stimulation through the TGF-β-MRTF axis inhibited by aspirin;Cell Communication and Signaling;2024-05-28
4. Efficacy and safety of antiplatelet therapy in COVID-19: Insights from a meta-analysis of randomized controlled trials;Int. Journal of Clinical Pharmacology and Therapeutics;2024-05-01
5. Understanding Antithrombotic Agents for Rehabilitation Therapy: A Comprehensive Narrative Review;Cureus;2024-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3